NovoCure Ltd — Director's Dealing 2023

Nov 3, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2023-10-31

Reporting Person: Puri Michal Nath (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-10-31	Ordinary Shares	A	37593.00	$0.00	Acquired	37593.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-10-31	Stock Option (Right to Buy)	$13.30	A	57604.00	Acquired	2033-10-30	Ordinary Shares (57604.00)	Direct

Footnotes

F1: Represents restricted share units that are scheduled to vest in equal parts on the first, second and third anniversary of the grant date, subject to the reporting person's continued employment through such dates.

F2: These stock options will vest in equal parts on the first, second, third and fourth anniversary of the grant date.